Clinical Trial Update: A Study to Learn How the Study Medicine Called Sisunatovir is Tolerated and Acts in the Bodies of Chinese Healthy Adults. [Phase 1]

View source ↗

Summary

Pfizer conducted a Phase 1 study in healthy Chinese adults to evaluate tolerability, safety, and pharmacokinetics of sisunatovir; the trial has completed and re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Respiratory Syncytial Virus Infection

Drugs mentioned

• Sisunatovir (Sisunatovir)

Snippet

Sponsor: Pfizer | Conditions: Respiratory Syncytial Virus Infection | Phase 1 | Status: COMPLETED | Results posted: 2025-02-24